Cellectis（NASDAQ: CLLS）报告季度每股亏损为$(0.16)，优于分析师的共识预期$(0.17)，超出5.88%。相比去年同期每股亏损$(0.57)，这是一增长了71.93%。公司报告季度销售额为3322万美元，超出分析师的共识预期945万美元，超出251.59%。相比去年同期销售额199万美元，增长了1.57千%。

以上内容来自Benzinga Earnings专栏，原文如下：

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.17) by 5.88 percent. This is a 71.93 percent increase over losses of $(0.57) per share from the same period last year. The company reported quarterly sales of $33.22 million which beat the analyst consensus estimate of $9.45 million by 251.59 percent. This is a 1.57K percent increase over sales of $1.99 million the same period last year.